The changing pattern of hospital care for persons living with HIV: 2000 through 2004

Journal of Acquired Immune Deficiency Syndromes

Volumn 45, Issue 2, 2007, Pages 239-246

  Hellinger, Fred J ^a  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

Cost; Hospital care; Length of stay

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENDER; GROUPS BY AGE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH PROGRAM; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HOSPITAL COSTS; HOSPITALS; HUMANS; INFANT; LENGTH OF STAY; MALE; MIDDLE AGED; TIME FACTORS; UNITED STATES;

EID: 34249874624     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3180517407     Document Type: Article

References (41)

1. Kates J. US Federal Funding for HIV/AIDS: The FY 2007 Request, HIV/AIDS Policy Fact Sheet. Menlo Park, CA: The Henry J. Kaiser Family Foundation; 2006.
2. AIDS Drug Assistance Programs (ADAPs). HIV/AIDS Policy Fact Sheet. Menlo Park, CA: The Henry J. Kaiser Family Foundation; 2002.
3. Hellinger FJ. Cost and financing of care for persons with HIV disease. An overview. Health Care Financ Rev. 1998;19:5-18.
4. Hardy AM, Rauch K, Echenberg D, et al. The economic impact of the first 10,000 cases of acquired immunodeficiency syndrome in the United States. JAMA. 1986;255:209-211.
5. Bozzette SA, Geoffrey J, McCaffrey DF, et al. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. N Engl J Med. 2001;344:817-823.
6. Hellinger FJ. Forecasting the medical care costs of the HIV epidemic: 1991-1994. Inquiry. 1991;28:213-225.
7. Andrulis DP, Beers JD, Bentley JD, et al. The provision and financing of medical care for AIDS patients in US public and private teaching hospitals. JAMA. 1987;258:1343-1346.
8. Andrulis DP, Weslowski VB, Gage LS. The 1987 US Hospital AIDS Survey. JAMA. 1989;262:784-794.
9. Andrulis DP, Weslowski VB, Hintz E, et al. Comparisons of hospital care for patients with AIDS and other HIV-related conditions. JAMA. 1992;267:2482-2486.
10. Goldman DP, Leibowitz AA, Shapiro MF, et al. The impact of state policy on the costs of HIV infection. Med Care Res Rev. 2001;58:31-53.
11. Manning WG, Leibowitz A, Goldberg GA, et al. A controlled trial of the effect of a prepaid group practice on use of services. N Engl J Med. 1984;310:1505-1510.
12. Greenfield S, Nelson EC, Zubkoff M, et al. Variations in resource utilization among medical specialties and systems of care. Results from the medical outcomes study. JAMA. 1992;267:1624-1630.
13. Wennberg JE. Future directions for small area variations. Med Care. 1993;5(Suppl):YS75-YS80.
14. Wennberg JE. Practice variations and the challenge to leadership. Spine. 1996;21:1472-1478.
15. Floris-Moore M, Lo Y, Klein RS, et al. Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2003;34:331-337.
16. Hellinger FJ. HIV patients in the HCUP database: a study of hospital utilization and costs. Inquiry. 2004;41:95-105.
17. Gebo KA, Fleishman JA, Moore RD. Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states. J Acquir Immune Defic Syndr. 2005;40:609-616.
18. Fleishman JA, Hellinger FJ. Recent trends in HIV-related inpatient admissions 1996-2000: a 7-state study. J Acquir Immune Defic Syndr. 2003;34:102-110.
19. US Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report: Cases of HIV Infection and AIDS in the United States, 2004, vol. 16. Atlanta, GA: US Department of Health and Human Services; 2005.
20. Fleishman JA, Gebo KA, Reilly ED, et al. Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002. Med Care. 2005;43(Suppl 9):40-52.
21. HCUP SID Database Documentation. Healthcare Cost and Utilization Project (HCUP), January 2007. Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.hcup-us.abrq.gov/db/state/siddbdocumentation.jsp.
22. US Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report: US HIV and AIDS Cases Reported through December 2000, vol. 12, no. 2. Atlanta, GA: US Department of Health and Human Services; 2001.
23. California Department of Health Services. The Office of AIDS, HIV/AIDS Case Registry Section, HIV Cumulative Surveillance Report. Sacramento, CA: California Department of Health Services; 2005.
24. Washington State Department of Health. Washington State HIV/AIDS Surveillance Report - July 2006. Olympia, WA: Washington State Department of Health, IDRH Assessment Unit; 2006.
25. US Centers for Disease Control and Prevention. HIV/AIDS Surveillance Technical Report: HIV Infection in Areas Conducting HIV Reporting Using Patient Identifiers, 2000, vol. 1, no. 1, Atlanta, GA: US Department of Health and Human Services; 2001.
26. Rosenblum L, Buehler JW, Morgan MW, et al. HIV infection in hospitalized patients and Medicaid enrollees: the accuracy of medical record coding. Am J Public Health. 1993;83:1457-1459.
27. Fasciano NJ, Cherlow AL, Turner BJ, et al. Profile of Medicare beneficiaries with AIDS: application of AIDS casefinding algorithm. Health Care Financ Rev. 1998;19:19-38.
28. SAS Institute. SAS/STAT User's Guide, Version 8, vol. 2. Cary, NC: SAS Institute; 1999.
29. Cameron AC, Trivedi PK. Regression Analysis of Count Data. Cambridge University Press, Cambridge, UK; 1998.
30. Friedman B, De La Mare J, Andrews R, et al. Practical options for estimating cost of hospital inpatient stays. J Health Care Finance. 2002;29:1-13.
31. Cost-to-Charge Ratio Files. Healthcare Cost and Utilization Project (HCUP), October 2006. Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.hcup-us.abrq.gov/db/state/costtocharge.jsp.
32. Moore RD, Chaisson RE. Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:223-231.
33. Greene WH. Econometric Analysis. 2nd ed. New York: Macmillan Publishing Company; 1993.
34. Liang KL, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
35. Moore RD, Keruly JC. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis. 2007;44:441-446.
36. Nogueras M, Navarro G, Anton E, et al. Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more. BMC Infect Dis. 2006;6:159-167.
37. Hall HI, McDavid K, Ling Q, et al. Determinants of progression to AIDS or death after HIV diagnosis, United States, 1996 to 2001. Ann Epidemiol. 2006;16:824-833.
38. Betz ME, Gebo KA, Barber E, et al. Patterns of diagnoses in hospital admissions in a multistate cohort of HIV-positive adults in 2001. Med Care. 2005;43(Suppl):III-3-III-14.
39. Nunez MJ, Martin-Carbonero L, Moreno V, et al. Impact of antiretroviral treatment-related toxicities on hospital admissions in HIV-infected patients. AIDS Res Hum Retroviruses. 2006;22:825-829.
40. Hellinger F. The lifetime cost of treating a person with HIV. JAMA. 1993;270:474-478.
41. Aschman DJ. HIV Capitation Risk Adjustment Conference Report. Conference sponsored by the Health Resources and Services Administration, US Department of Health and Human Services, in conjunction with the Henry J. Kaiser Family Foundation, Washington, DC, May 28-29, 1997.